Search
for
Sort by
Research 121–150 of 1000+
- Prognosis and Management of Congenital Hair Shaft Disorders with Fragility—Part I
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Scalp Itch: A Systematic Review
- Hypersensitivity Reactions to Anticoagulant Drugs
- Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation
- Androgen antagonists in androgen target tissues
- INTERFERONS IN DERMATOLOGY
- The Contribution of Endogenous and Exogenous Factors to Female Alopecia
- An Update on Drug-Induced Pigmentation
- Problems and Solutions for Platelet-Rich Plasma in Facial Rejuvenation: A Systematic Review
- Skin manifestations of chronic kidney disease
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Skin diseases in consequence of endocrine alterations
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Cutaneous Blood Flow.
- Biology of Human Hair: Know Your Hair to Control It
- Psychoactive drugs and skin
- Protein and amino acid composition of hair from mice carrying the naked (<i>N</i>) gene
- Drug eruptions in dermatology
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
- Hyperadrenocorticism in Ferrets
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- A case report of a novel, integrative approach to Hashimoto’s thyroiditis with unexpected results
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women